{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T00:46:07Z","timestamp":1794357967949,"version":"4.9.0"},"publisher-location":"Dordrecht","reference-count":165,"publisher":"Springer Netherlands","isbn-type":[{"value":"9781402088308","type":"print"},{"value":"9781402088315","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1007\/978-1-4020-8830-8_12","type":"book-chapter","created":{"date-parts":[[2008,8,26]],"date-time":"2008-08-26T06:33:46Z","timestamp":1219732426000},"page":"325-350","source":"Crossref","is-referenced-by-count":64,"title":["The Role of Phospholipid Oxidation Products in Inflammatory and Autoimmune Diseases"],"prefix":"10.1007","author":[{"given":"Norbert","family":"Leitinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"12_CR1","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/cbf.1070","volume":"22","author":"B. Agachan","year":"2004","unstructured":"Agachan, B. et al. \"Paraoxonase 55 and 192 polymorphism and its relationship to serum paraoxonase activity and serum lipids in Turkish patients with non-insulin dependent diabetes mellitus.\" Cell Biochem. Funct. 22 (2004) 163\u20138.","journal-title":"Cell Biochem. Funct"},{"key":"12_CR2","doi-asserted-by":"crossref","first-page":"24473","DOI":"10.1074\/jbc.M010459200","volume":"276","author":"Z. Ahmed","year":"2001","unstructured":"Ahmed, Z. et al. \"Apolipoprotein A-I promotes the formation of phosphatidylcholine core aldehydes that are hydrolyzed by paraoxonase (PON-1) during high density lipoprotein oxidation with a peroxynitrite donor.\" J. Biol. Chem. 276 (2001) 24473\u201381.","journal-title":"J. Biol. Chem"},{"key":"12_CR3","doi-asserted-by":"crossref","first-page":"712","DOI":"10.2353\/ajpath.2007.070463","volume":"171","author":"A. Alisi","year":"2007","unstructured":"Alisi, A. and V. Nobili \"Molecular pathogenesis of nonalcoholic steatohepatitis: today and tomorrow.\" Am. J. Pathol. 171 (2007) 712\u20133.","journal-title":"Am. J. Pathol"},{"key":"12_CR4","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1111\/j.0022-202X.2004.22421.x","volume":"122","author":"M. Allanson","year":"2004","unstructured":"Allanson, M. and V.E. Reeve \"Immunoprotective UVA (320\u2013400\u00a0nm) irradiation upregulates heme oxygenase-1 in the dermis and epidermis of hairless mouse skin.\" J. Invest Dermatol. 122 (2004) 1030\u20136.","journal-title":"J. Invest Dermatol"},{"key":"12_CR5","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1365-2249.1995.tb08344.x","volume":"101","author":"A. Amara","year":"1995","unstructured":"Amara, A. et al. \"Autoantibodies to malondialdehyde-modified epitope in connective tissue diseases and vasculitides.\" Clin. Exp. Immunol 101 (1995) 233\u20138.","journal-title":"Clin. Exp. Immunol"},{"key":"12_CR6","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.immuni.2004.09.003","volume":"21","author":"V. Angeli","year":"2004","unstructured":"Angeli, V. et al. \"Dyslipidemia associated with atherosclerotic disease systemically alters dendritic cell mobilization.\" Immunity 21 (2004) 561\u201374.","journal-title":"Immunity"},{"key":"12_CR7","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/oxfordjournals.jbchem.a003145","volume":"131","author":"H. Arai","year":"2002","unstructured":"Arai, H. et al. \"Platelet-activating factor acetylhydrolase (PAF-AH).\" J. Biochem. (Tokyo) 131 (2002) 635\u201340.","journal-title":"J. Biochem. (Tokyo)"},{"key":"12_CR8","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1038\/sj.jid.5700741","volume":"127","author":"J. Baier","year":"2007","unstructured":"Baier, J. et al. \"Direct detection of singlet oxygen generated by UVA irradiation in human cells and skin.\" J. Invest Dermatol. 127 (2007) 1498\u2013506.","journal-title":"J. Invest Dermatol"},{"key":"12_CR9","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/0891-5849(95)02182-5","volume":"20","author":"S. Basu-Modak","year":"1996","unstructured":"Basu-Modak, S., P. Luscher, and R.M. Tyrrell \"Lipid metabolite involvement in the activation of the human heme oxygenase-1 gene.\" Free Radic. Biol. Med. 20 (1996) 887\u201397.","journal-title":"Free Radic. Biol. Med"},{"key":"12_CR10","first-page":"4505","volume":"53","author":"S. Basu-Modak","year":"1993","unstructured":"Basu-Modak, S. and R.M. Tyrrell \"Singlet oxygen: a primary effector in the ultraviolet A\/near-visible light induction of the human heme oxygenase gene.\" Cancer Res. 53 (1993) 4505\u201310.","journal-title":"Cancer Res"},{"key":"12_CR11","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1161\/01.CIR.91.9.2488","volume":"91","author":"J.A. Berliner","year":"1995","unstructured":"Berliner, J.A. et al. \"Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics.\" Circulation 91 (1995) 2488\u201396.","journal-title":"Circulation"},{"key":"12_CR12","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S1050-1738(01)00098-6","volume":"11","author":"J.A. Berliner","year":"2001","unstructured":"Berliner, J.A. et al. \"Evidence for a role of phospholipid oxidation products in atherogenesis.\" Trends Cardiovasc. Med. 11 (2001) 142\u20137.","journal-title":"Trends Cardiovasc. Med"},{"key":"12_CR13","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1172\/JCI114562","volume":"85","author":"J.A. Berliner","year":"1990","unstructured":"Berliner, J.A. et al. \"Minimally modified low density lipoprotein stimulates monocyte endothelial interactions.\" J. Clin. Invest 85 (1990) 1260\u20136.","journal-title":"J. Clin. Invest"},{"key":"12_CR14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMp058118","volume":"353","author":"J.A. Berliner","year":"2005","unstructured":"Berliner, J.A. and A.D. Watson \"A role for oxidized phospholipids in atherosclerosis.\" N. Engl. J. Med. 353 (2005) 9\u201311.","journal-title":"N. Engl. J. Med"},{"key":"12_CR15","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/cbf.1288","volume":"25","author":"I. Bilge","year":"2007","unstructured":"Bilge, I. et al. \"Is paraoxonase 192 gene polymorphism a risk factor for membranoproliferative glomerulonephritis in children?\" Cell Biochem. Funct. 25 (2007) 159\u201365.","journal-title":"Cell Biochem. Funct"},{"key":"12_CR16","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1038\/nm1102-1218","volume":"8","author":"C.J. Binder","year":"2002","unstructured":"Binder, C.J. et al. \"Innate and acquired immunity in atherogenesis.\" Nat. Med. 8 (2002): 1218\u201326.","journal-title":"Nat. Med"},{"key":"12_CR17","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nm876","volume":"9","author":"C.J. Binder","year":"2003","unstructured":"Binder, C.J. et al. \"Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL.\" Nat. Med. 9 (2003) 736\u201343.","journal-title":"Nat. Med"},{"key":"12_CR18","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1194\/jlr.R500005-JLR200","volume":"46","author":"C.J. Binder","year":"2005","unstructured":"Binder, C.J. et al. \"The role of natural antibodies in atherogenesis.\" J. Lipid Res. 46 (2005) 1353\u201363.","journal-title":"J. Lipid Res"},{"key":"12_CR19","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/01.RES.0000147310.18962.06","volume":"95","author":"K.G. Birukov","year":"2004","unstructured":"Birukov, K.G. et al. \"Epoxycyclopentenone-containing oxidized phospholipids restore endothelial barrier function via Cdc42 and Rac.\" Circ. Res. 95 (2004) 892\u2013901.","journal-title":"Circ. Res"},{"key":"12_CR20","doi-asserted-by":"crossref","first-page":"L924","DOI":"10.1152\/ajplung.00395.2006","volume":"292","author":"A.A. Birukova","year":"2007","unstructured":"Birukova, A.A. et al. \"Polar head groups are important for barrier-protective effects of oxidized phospholipids on pulmonary endothelium.\" Am. J. Physiol Lung Cell Mol. Physiol 292 (2007) L924\u2013L935.","journal-title":"Am. J. Physiol Lung Cell Mol. Physiol"},{"key":"12_CR21","doi-asserted-by":"crossref","first-page":"501","DOI":"10.4049\/jimmunol.175.1.501","volume":"175","author":"S. Bluml","year":"2005","unstructured":"Bluml, S. et al. \"Oxidized phospholipids negatively regulate dendritic cell maturation induced by TLRs and CD40.\" J. Immunol. 175 (2005) 501\u20138.","journal-title":"J. Immunol"},{"key":"12_CR22","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1160\/TH06-08-0474","volume":"97","author":"V.N. Bochkov","year":"2007","unstructured":"Bochkov, V.N. \"Inflammatory profile of oxidized phospholipids.\" Thromb. Haemost. 97 (2007) 348\u201354.","journal-title":"Thromb. Haemost"},{"key":"12_CR23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nature01023","volume":"419","author":"V.N. Bochkov","year":"2002a","unstructured":"Bochkov, V.N. et al. \"Protective role of phospholipid oxidation products in endotoxin-induced tissue damage.\" Nature 419 (2002a) 77\u201381.","journal-title":"Nature"},{"key":"12_CR24","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00109-003-0467-2","volume":"81","author":"V.N. Bochkov","year":"2003","unstructured":"Bochkov, V.N. and N. Leitinger \"Anti-inflammatory properties of lipid oxidation products.\" J. Mol. Med. 81 (2003) 613\u201326.","journal-title":"J. Mol. Med"},{"key":"12_CR25","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1182\/blood.V99.1.199","volume":"99","author":"V.N. Bochkov","year":"2002b","unstructured":"Bochkov, V.N. et al. \"Oxidized phospholipids stimulate tissue factor expression in human endothelial cells via activation of ERK\/EGR-1 and Ca(++)\/NFAT.\" Blood 99 (2002b) 199\u2013206.","journal-title":"Blood"},{"key":"12_CR26","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1161\/01.RES.0000245485.04489.ee","volume":"99","author":"V.N. Bochkov","year":"2006","unstructured":"Bochkov, V.N. et al. \"Oxidized phospholipids stimulate angiogenesis via autocrine mechanisms, implicating a novel role for lipid oxidation in the evolution of atherosclerotic lesions.\" Circ. Res. 99 (2006) 900\u20138.","journal-title":"Circ. Res"},{"key":"12_CR27","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1159\/000112465","volume":"25","author":"M. Bossola","year":"2007","unstructured":"Bossola, M. et al. \"Oxidized low-density lipoprotein biomarkers in patients with end-stage renal failure: Acute effects of hemodialysis.\" Blood Purif. 25 (2007) 457\u201365.","journal-title":"Blood Purif"},{"key":"12_CR28","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1194\/jlr.M400496-JLR200","volume":"46","author":"A. Boullier","year":"2005","unstructured":"Boullier, A. et al. \"Phosphocholine as a pattern recognition ligand for CD36.\" J. Lipid Res. 46 (2005) 969\u201376.","journal-title":"J. Lipid Res"},{"key":"12_CR29","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1194\/jlr.M700433-JLR200","volume":"49","author":"G.M. Buga","year":"2008","unstructured":"Buga, G.M. et al. \"D-4F reduces EO6 immunoreactivity, SREBP-1c mRNA levels, and renal inflammation in LDL receptor-null mice fed a Western diet.\" J. Lipid Res. 49 (2008) 192\u2013205.","journal-title":"J. Lipid Res"},{"key":"12_CR30","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0021-9150(98)00031-8","volume":"138","author":"H. Cao","year":"1998","unstructured":"Cao, H. et al. \"Lack of association between carotid intima-media thickness and paraoxonase gene polymorphism in non-insulin dependent diabetes mellitus.\" Atherosclerosis 138 (1998) 361\u20136.","journal-title":"Atherosclerosis"},{"key":"12_CR31","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1080\/07853890701436757","volume":"39","author":"C.E. Chadjichristos","year":"2007","unstructured":"Chadjichristos, C.E. and B.R. Kwak \"Connexins: new genes in atherosclerosis.\" Ann. Med. 39 (2007) 402\u201311.","journal-title":"Ann. Med"},{"key":"12_CR32","doi-asserted-by":"crossref","first-page":"6353","DOI":"10.1073\/pnas.96.11.6353","volume":"96","author":"M.K. Chang","year":"1999","unstructured":"Chang, M.K. et al. \"Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: evidence that oxidation-specific epitopes mediate macrophage recognition.\" Proc. Natl. Acad. Sci. USA 96 (1999) 6353\u20138.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"12_CR33","doi-asserted-by":"crossref","first-page":"13043","DOI":"10.1073\/pnas.192399699","volume":"99","author":"M.K. Chang","year":"2002","unstructured":"Chang, M.K. et al. \"C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids.\" Proc. Natl. Acad. Sci. USA 99 (2002) 13043\u20138.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"12_CR34","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1023\/B:GLYC.0000033629.54962.68","volume":"20","author":"S. Chatterjee","year":"2004","unstructured":"Chatterjee, S. et al. \"Identification of a biologically active component in minimally oxidized low density lipoprotein (MM-LDL) responsible for aortic smooth muscle cell proliferation.\" Glycoconj. J 20 (2004) 331\u20138.","journal-title":"Glycoconj. J"},{"key":"12_CR35","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1093\/rheumatology\/41.9.988","volume":"41","author":"J.T. Cvetkovic","year":"2002","unstructured":"Cvetkovic, J.T. et al. \"Increased levels of autoantibodies against copper-oxidized low density lipoprotein, malondialdehyde-modified low density lipoprotein and cardiolipin in patients with rheumatoid arthritis.\" Rheumatology (Oxford) 41 (2002) 988\u201395.","journal-title":"Rheumatology (Oxford)"},{"key":"12_CR36","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1161\/01.CIR.103.18.2277","volume":"103","author":"T. Cyrus","year":"2001","unstructured":"Cyrus, T. et al. \"Absence of 12\/15-lipoxygenase expression decreases lipid peroxidation and atherogenesis in apolipoprotein e-deficient mice.\" Circulation 103 (2001) 2277\u201382.","journal-title":"Circulation"},{"key":"12_CR37","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1586\/14737159.2.1.17","volume":"2","author":"N. Dada","year":"2002","unstructured":"Dada, N., N.W. Kim, and R.L. Wolfert \"Lp-PLA2: an emerging biomarker of coronary heart disease.\" Expert. Rev. Mol. Diagn. 2 (2002) 17\u201322.","journal-title":"Expert. Rev. Mol. Diagn"},{"key":"12_CR38","doi-asserted-by":"crossref","first-page":"H674","DOI":"10.1152\/ajpheart.00554.2005","volume":"290","author":"L. DeMaio","year":"2006","unstructured":"DeMaio, L. et al. \"Oxidized phospholipids mediate occludin expression and phosphorylation in vascular endothelial cells.\" Am. J. Physiol Heart Circ. Physiol 290 (2006) H674\u2013H683.","journal-title":"Am. J. Physiol Heart Circ. Physiol"},{"key":"12_CR39","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/00019501-199912000-00008","volume":"10","author":"M. Dessi","year":"1999","unstructured":"Dessi, M. et al. \"Influence of the human paraoxonase polymorphism (PON1 192) on the carotid-wall thickening in a healthy population.\" Coron. Artery Dis. 10 (1999) 595\u20139.","journal-title":"Coron. Artery Dis"},{"key":"12_CR40","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1046\/j.1523-1755.2000.00814.x","volume":"57","author":"J.H. Dominguez","year":"2000","unstructured":"Dominguez, J.H. et al. \"Studies of renal injury III: Lipid-induced nephropathy in type II diabetes.\" Kidney Int. 57 (2000) 92\u2013104.","journal-title":"Kidney Int"},{"key":"12_CR41","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0008-6363(02)00437-6","volume":"55","author":"S. Eligini","year":"2002","unstructured":"Eligini, S. et al. \"Oxidized phospholipids inhibit cyclooxygenase-2 in human macrophages via nuclear factor-kappaB\/IkappaB- and ERK2-dependent mechanisms.\" Cardiovasc. Res. 55 (2002) 406\u201315.","journal-title":"Cardiovasc. Res"},{"key":"12_CR42","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0022-2275(20)38678-8","volume":"28","author":"H. Esterbauer","year":"1987","unstructured":"Esterbauer, H. et al. \"Autoxidation of human low density lipoprotein: loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes.\" J. Lipid. Res. 28 (1987) 495\u2013509.","journal-title":"J. Lipid. Res"},{"key":"12_CR43","first-page":"1313","volume":"149","author":"M. Exner","year":"1996","unstructured":"Exner, M. et al. \"Lipoproteins accumulate in immune deposits and are modified by lipid peroxidation in passive Heymann nephritis.\" Am. J. Pathol. 149 (1996) 1313\u201320.","journal-title":"Am. J. Pathol"},{"key":"12_CR44","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1172\/JCI9259","volume":"105","author":"M. Febbraio","year":"2000","unstructured":"Febbraio, M. et al. \"Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice.\" J. Clin. Invest 105 (2000) 1049\u201356.","journal-title":"J. Clin. Invest"},{"key":"12_CR45","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1194\/jlr.M600512-JLR200","volume":"48","author":"X. Feng","year":"2007","unstructured":"Feng, X. et al. \"ApoE-\/-Fas-\/- C57BL\/6 mice: a novel murine model simultaneously exhibits lupus nephritis, atherosclerosis, and osteopenia.\" J. Lipid Res. 48 (2007) 794\u2013805.","journal-title":"J. Lipid Res"},{"key":"12_CR46","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0021-9150(02)00423-9","volume":"167","author":"G. Fortunato","year":"2003","unstructured":"Fortunato, G. et al. \"A paraoxonase gene polymorphism, PON 1 (55), as an independent risk factor for increased carotid intima-media thickness in middle-aged women.\" Atherosclerosis 167 (2003) 141\u20138.","journal-title":"Atherosclerosis"},{"key":"12_CR47","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0002-9394(00)00643-7","volume":"130","author":"E. Friedman","year":"2000","unstructured":"Friedman, E. \"The role of the atherosclerotic process in the pathogenesis of age-related macular degeneration.\" Am. J. Ophthalmol. 130 (2000) 658\u201363.","journal-title":"Am. J. Ophthalmol"},{"key":"12_CR48","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/art.20780","volume":"52","author":"J. Frostegard","year":"2005","unstructured":"Frostegard, J. et al. \"Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations.\" Arthritis Rheum. 52 (2005) 192\u2013200.","journal-title":"Arthritis Rheum"},{"key":"12_CR49","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.bbadis.2007.04.009","volume":"1772","author":"G.O. Fruhwirth","year":"2007","unstructured":"Fruhwirth, G.O., A. Loidl, and A. Hermetter \"Oxidized phospholipids: From molecular properties to disease.\" Biochim. Biophys. Acta 1772 (2007) 718\u201336.","journal-title":"Biochim. Biophys. Acta"},{"key":"12_CR50","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/j.0022-202X.2005.23904.x","volume":"125","author":"L. Furio","year":"2005","unstructured":"Furio, L. et al. \"UVA radiation impairs phenotypic and functional maturation of human dermal dendritic cells.\" J. Invest Dermatol. 125 (2005) 1032\u20138.","journal-title":"J. Invest Dermatol"},{"key":"12_CR51","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1161\/01.ATV.0000153106.03644.a0","volume":"25","author":"A. Furnkranz","year":"2005","unstructured":"Furnkranz, A. et al. \"Oxidized phospholipids trigger atherogenic inflammation in murine arteries.\" Arteriosclerosis, Thrombosis, and Vascular Biology 25 (2005) 633\u20138.","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"12_CR52","doi-asserted-by":"crossref","first-page":"31298","DOI":"10.1074\/jbc.M604039200","volume":"281","author":"S. Gao","year":"2006","unstructured":"Gao, S. et al. \"Phospholipid hydroxyalkenals, a subset of recently discovered endogenous CD36 ligands, spontaneously generate novel furan-containing phospholipids lacking CD36 binding activity in vivo.\" J. Biol. Chem. 281 (2006) 31298\u2013308.","journal-title":"J. Biol. Chem"},{"key":"12_CR53","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1074\/jbc.M707348200","volume":"283","author":"M.E. Greenberg","year":"2008","unstructured":"Greenberg, M.E. et al. \"The lipid whisker model of the structure of oxidized cell membranes.\" J. Biol. Chem. 283 (2008) 2385\u201396.","journal-title":"J. Biol. Chem"},{"key":"12_CR54","doi-asserted-by":"crossref","first-page":"16934","DOI":"10.1074\/jbc.M702523200","volume":"282","author":"F. Gruber","year":"2007","unstructured":"Gruber, F. et al. \"Photooxidation generates biologically active phospholipids that induce heme oxygenase-1 in skin cells.\" J Biol. Chem. 282 (2007) 16934\u201341.","journal-title":"J Biol. Chem"},{"key":"12_CR55","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1034\/j.1600-0781.2001.170401.x","volume":"17","author":"C.J. Gruss","year":"2001","unstructured":"Gruss, C.J. et al. \"Effects of low dose ultraviolet A-1 phototherapy on morphea.\" Photodermatol. Photoimmunol. Photomed. 17 (2001) 149\u201355.","journal-title":"Photodermatol. Photoimmunol. Photomed"},{"key":"12_CR56","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/09533710022149368","volume":"13","author":"J. Hartwich","year":"2002","unstructured":"Hartwich, J. et al. \"Regulation of platelet adhesion by oxidized lipoproteins and oxidized phospholipids.\" Platelets. 13(May 2002) 141\u201351.","journal-title":"Platelets"},{"key":"12_CR57","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1191\/096120301667475689","volume":"10","author":"G. Hayem","year":"2001","unstructured":"Hayem, G. et al. \"Anti-oxidized low-density-lipoprotein (OxLDL) antibodies in systemic lupus erythematosus with and without antiphospholipid syndrome.\" Lupus 10 (2001) 346\u201351.","journal-title":"Lupus"},{"key":"12_CR58","doi-asserted-by":"crossref","first-page":"12515","DOI":"10.1073\/pnas.212532799","volume":"99","author":"S.L. Hazen","year":"2002","unstructured":"Hazen, S.L. and G.M. Chisolm \"Oxidized phosphatidylcholines: pattern recognition ligands for multiple pathways of the innate immune response.\" Proc. Natl. Acad. Sci. USA 99 (2002) 12515\u20137.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"12_CR59","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1172\/JCI118288","volume":"96","author":"J.M. Heery","year":"1995","unstructured":"Heery, J.M. et al. \"Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells.\" J. Clin. Invest. 96 (1995) 2322\u201330.","journal-title":"J. Clin. Invest"},{"key":"12_CR60","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0006-291X(02)02508-1","volume":"298","author":"S. Hiraishi","year":"2002","unstructured":"Hiraishi, S., S. Horie, and Y. Seyama \"Oxidation products of phospholipid-containing delta-9 fatty acids specifically impair the activity of tissue factor pathway inhibitor.\" Biochem. Biophys. Res. Commun. 298 (2002) 468\u201373.","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"12_CR61","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.thromres.2006.07.007","volume":"120","author":"G. Holzer","year":"2007","unstructured":"Holzer, G. et al. \"The dietary soy flavonoid genistein abrogates tissue factor induction in endothelial cells induced by the atherogenic oxidized phospholipid oxPAPC.\" Thromb. Res. 120 (2007) 71\u20139.","journal-title":"Thromb. Res"},{"key":"12_CR62","first-page":"2714","volume":"42","author":"G. Hoppe","year":"2001","unstructured":"Hoppe, G. et al. \"Oxidized low density lipoprotein-induced inhibition of processing of photoreceptor outer segments by RPE.\" Invest Ophthalmol. Vis. Sci. 42 (2001) 2714\u201320.","journal-title":"Invest Ophthalmol. Vis. Sci"},{"key":"12_CR63","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.bbadis.2004.01.004","volume":"1689","author":"G. Hoppe","year":"2004a","unstructured":"Hoppe, G. et al. \"Products of lipid peroxidation induce missorting of the principal lysosomal protease in retinal pigment epithelium.\" Biochim. Biophys. Acta 1689 (2004a) 33\u201341.","journal-title":"Biochim. Biophys. Acta"},{"key":"12_CR64","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1007\/s00018-004-4080-5","volume":"61","author":"G. Hoppe","year":"2004b","unstructured":"Hoppe, G. et al. \"Accumulation of oxidized lipid-protein complexes alters phagosome maturation in retinal pigment epithelium.\" Cell Mol. Life Sci. 61 (2004b) 1664\u201374.","journal-title":"Cell Mol. Life Sci"},{"key":"12_CR65","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/S0891-5849(00)00333-6","volume":"28","author":"S. Horkko","year":"2000","unstructured":"Horkko, S. et al. \"Immunological responses to oxidized LDL.\" Free Radic. Biol. Med. 28 (2000) 1771\u20139.","journal-title":"Free Radic. Biol. Med"},{"key":"12_CR66","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1172\/JCI4533","volume":"103","author":"S. Horkko","year":"1999","unstructured":"Horkko, S. et al. \"Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins.\" J. Clin. Invest. 103 (1999) 117\u201328.","journal-title":"J. Clin. Invest"},{"key":"12_CR67","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.freeradbiomed.2006.07.022","volume":"41","author":"L. Huang","year":"2006","unstructured":"Huang, L. et al. \"Oxidation-induced changes in human lens epithelial cells. 1. Phospholipids.\" Free Radic. Biol. Med. 41 (2006) 1425\u201332.","journal-title":"Free Radic. Biol. Med"},{"key":"12_CR68","doi-asserted-by":"crossref","first-page":"21237","DOI":"10.1074\/jbc.M701341200","volume":"282","author":"M.S. Huang","year":"2007","unstructured":"Huang, M.S. et al. \"Atherogenic phospholipids attenuate osteogenic signaling by BMP-2 and parathyroid hormone in osteoblasts.\" J. Biol. Chem. 282 (2007) 21237\u201343.","journal-title":"J. Biol. Chem"},{"key":"12_CR69","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1194\/jlr.M500555-JLR200","volume":"47","author":"J. Huber","year":"2006","unstructured":"Huber, J. et al. \"Specific monocyte adhesion to endothelial cells induced by oxidized phospholipids involves activation of cPLA2 and lipoxygenase.\" J. Lipid Res. 47 (2006) 1054\u201362.","journal-title":"J. Lipid Res"},{"key":"12_CR70","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1161\/hq0102.101525","volume":"22","author":"J. Huber","year":"2002","unstructured":"Huber, J. et al. \"Oxidized membrane vesicles and blebs from apoptotic cells contain biologically active oxidized phospholipids that induce monocyte-endothelial interactions.\" Arterioscler Thromb VAsc Biol 22 (2002) 101\u20137.","journal-title":"Arterioscler Thromb VAsc Biol"},{"key":"12_CR71","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0002-9394(01)00975-8","volume":"132","author":"T. Ikeda","year":"2001","unstructured":"Ikeda, T. et al. \"Paraoxonase gene polymorphisms and plasma oxidized low-density lipoprotein level as possible risk factors for exudative age-related macular degeneration.\" Am. J. Ophthalmol. 132 (2001) 191\u20135.","journal-title":"Am. J. Ophthalmol"},{"key":"12_CR72","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/hep.21070","volume":"43","author":"Y. Ikura","year":"2006","unstructured":"Ikura, Y. et al. \"Localization of oxidized phosphatidylcholine in nonalcoholic fatty liver disease: impact on disease progression.\" Hepatology 43 (2006) 506\u201314.","journal-title":"Hepatology"},{"key":"12_CR73","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1161\/01.ATV.0000237608.19055.53","volume":"26","author":"B.E. Isakson","year":"2006","unstructured":"Isakson, B.E. et al. \"Oxidized phospholipids alter vascular connexin expression, phosphorylation, and heterocellular communication.\" Arterioscler. Thromb. Vasc. Biol. 26 (2006) 2216\u201321.","journal-title":"Arterioscler. Thromb. Vasc. Biol"},{"key":"12_CR74","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.1182\/blood-2002-08-2428","volume":"101","author":"H. Ishii","year":"2003","unstructured":"Ishii, H. et al. \"Oxidized phospholipids in oxidized low-density lipoprotein downregulate thrombomodulin transcription in vascular endothelial cells through a decrease in the binding of RAR{beta}-RXR{alpha} heterodimers and Sp1 and 3 to their binding sequences in the TM promoter.\" Blood 101 (2003) 4767\u201374.","journal-title":"Blood"},{"key":"12_CR75","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1172\/JCI119634","volume":"100","author":"K. Ishikawa","year":"1997","unstructured":"Ishikawa, K. et al. \"Induction of heme oxygenase-1 inhibits the monocyte transmigration induced by mildly oxidized LDL.\" J. Clin. Invest. 100 (1997) 1209\u201316.","journal-title":"J. Clin. Invest"},{"key":"12_CR76","doi-asserted-by":"crossref","first-page":"15274","DOI":"10.1016\/S0021-9258(17)36602-4","volume":"269","author":"H. Itabe","year":"1994","unstructured":"Itabe, H. et al. \"A monoclonal antibody against oxidized lipoprotein recognizes foam cells in atherosclerotic lesions. Complex formation of oxidized phosphatidylcholines and polypeptides.\" J. Biol. Chem. 269 (1994) 15274\u20139.","journal-title":"J. Biol. Chem"},{"key":"12_CR77","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1194\/jlr.M300129-JLR200","volume":"44","author":"A.I. Kakafika","year":"2003","unstructured":"Kakafika, A.I. et al. \"The PON1 M55L gene polymorphism is associated with reduced HDL-associated PAF-AH activity.\" J. Lipid Res. 44 (2003) 1919\u201326.","journal-title":"J. Lipid Res"},{"key":"12_CR78","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.atherosclerosis.2004.10.046","volume":"182","author":"N. Khuseyinova","year":"2005","unstructured":"Khuseyinova, N. et al. \"Association between Lp-PLA2 and coronary artery disease: focus on its relationship with lipoproteins and markers of inflammation and hemostasis.\" Atherosclerosis 182 (2005) 181\u20138.","journal-title":"Atherosclerosis"},{"key":"12_CR79","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1161\/ATVBAHA.107.145805","volume":"27","author":"S. Kiechl","year":"2007","unstructured":"Kiechl, S. et al. \"Oxidized phospholipids, lipoprotein(a), lipoprotein-associated phospholipase A2 activity, and 10-year cardiovascular outcomes: prospective results from the Bruneck study.\" Arterioscler. Thromb. Vasc. Biol. 27 (2007) 1788\u201395.","journal-title":"Arterioscler. Thromb. Vasc. Biol"},{"key":"12_CR80","doi-asserted-by":"crossref","first-page":"993","DOI":"10.4049\/jimmunol.178.2.993","volume":"178","author":"S. Knapp","year":"2007","unstructured":"Knapp, S. et al. \"Oxidized phospholipids inhibit phagocytosis and impair outcome in gram-negative sepsis in vivo.\" J. Immunol. 178 (2007) 993\u20131001.","journal-title":"J. Immunol"},{"key":"12_CR81","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1074\/jbc.M708622200","volume":"283","author":"N. Kono","year":"2008","unstructured":"Kono, N. et al. \"Protection against oxidative stress-induced hepatic injury by intracellular type II platelet-activating factor acetylhydrolase by metabolism of oxidized phospholipids in vivo.\" J. Biol. Chem. 283 (2008) 1628\u201336.","journal-title":"J. Biol. Chem"},{"key":"12_CR82","doi-asserted-by":"crossref","first-page":"10011","DOI":"10.1021\/bi000619d","volume":"39","author":"V. Koppaka","year":"2000","unstructured":"Koppaka, V. and P.H. Axelsen \"Accelerated accumulation of amyloid beta proteins on oxidatively damaged lipid membranes.\" Biochemistry 39 (2000) 10011\u20136.","journal-title":"Biochemistry"},{"key":"12_CR83","doi-asserted-by":"crossref","first-page":"36277","DOI":"10.1074\/jbc.M301334200","volume":"278","author":"V. Koppaka","year":"2003","unstructured":"Koppaka, V. et al. \"Early synergy between Abeta42 and oxidatively damaged membranes in promoting amyloid fibril formation by Abeta40.\" J. Biol. Chem. 278 (2003) 36277\u201384.","journal-title":"J. Biol. Chem"},{"key":"12_CR84","doi-asserted-by":"crossref","first-page":"51006","DOI":"10.1074\/jbc.M304103200","volume":"278","author":"G. Kronke","year":"2003","unstructured":"Kronke, G. et al. \"Oxidized phospholipids induce expression of human heme oxygenase-1 involving activation of cAMP-responsive element-binding protein.\" J. Biol. Chem. 278 (2003) 51006\u201314.","journal-title":"J. Biol. Chem"},{"key":"12_CR85","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2217\/17460875.1.5.623","volume":"1","author":"G. Kronke","year":"2006","unstructured":"Kronke, G. and N. Leitinger \"Oxidized phospholipids at the interface of innate and adaptive immunity.\" Future Lipidol. 1 (2006) 623\u201330.","journal-title":"Future Lipidol"},{"key":"12_CR86","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1161\/01.CIR.0000051364.70064.D1","volume":"107","author":"B.R. Kwak","year":"2003","unstructured":"Kwak, B.R. et al. \"Reduced connexin43 expression inhibits atherosclerotic lesion formation in low-density lipoprotein receptor-deficient mice.\" Circulation 107 (2003) 1033\u20139.","journal-title":"Circulation"},{"key":"12_CR87","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0022-2275(20)32409-3","volume":"41","author":"D.T. Laskowitz","year":"2000","unstructured":"Laskowitz, D.T. et al. \"Altered immune responses in apolipoprotein E-deficient mice.\" J. Lipid Res. 41 (2000) 613\u201320.","journal-title":"J. Lipid Res"},{"key":"12_CR88","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.jaad.2004.04.029","volume":"51","author":"F.J. Legat","year":"2004a","unstructured":"Legat, F.J. et al. \"Reduction of treatment frequency and UVA dose does not substantially compromise the antipsoriatic effect of oral psoralen-UVA.\" J. Am. Acad. Dermatol. 51 (2004a) 746\u201354.","journal-title":"J. Am. Acad. Dermatol"},{"key":"12_CR89","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.0906-6705.2004.00185.x","volume":"13","author":"F.J. Legat","year":"2004b","unstructured":"Legat, F.J. et al. \"The role of calcitonin gene-related peptide in cutaneous immunosuppression induced by repeated subinflammatory ultraviolet irradiation exposure.\" Exp. Dermatol. 13 (2004b) 242\u201350.","journal-title":"Exp. Dermatol"},{"key":"12_CR90","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/mnfr.200500086","volume":"49","author":"N. Leitinger","year":"2005","unstructured":"Leitinger, N. \"Oxidized phospholipids as triggers of inflammation in atherosclerosis.\" Mol. Nutr. Food Res. 49 (2005) 1063\u201371.","journal-title":"Mol. Nutr. Food Res"},{"key":"12_CR91","doi-asserted-by":"crossref","first-page":"12010","DOI":"10.1073\/pnas.96.21.12010","volume":"96","author":"N. Leitinger","year":"1999","unstructured":"Leitinger, N. et al. \"Structurally similar oxidized phospholipids differentially regulate endothelial binding of monocytes and neutrophils.\" Proc. Natl. Acad. Sci. USA 96 (1999) 12010\u20135.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"12_CR92","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1097\/mpa.0b013e3181525855","volume":"35","author":"L. Li","year":"2007","unstructured":"Li, L., X.P. Wang, and K. Wu \"The therapeutic effect of oxidized 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine in rodents with acute necrotizing pancreatitis and its mechanism.\" Pancreas 35 (2007) e27\u2013e36.","journal-title":"Pancreas"},{"key":"12_CR93","doi-asserted-by":"crossref","first-page":"32921","DOI":"10.1074\/jbc.M306088200","volume":"278","author":"A. Loidl","year":"2003","unstructured":"Loidl, A. et al. \"Oxidized phospholipids in minimally modified low density lipoprotein induce apoptotic signaling via activation of acid sphingomyelinase in arterial smooth muscle cells.\" J Biol Chem. 278 (2003) 32921\u20138.","journal-title":"J Biol Chem"},{"key":"12_CR94","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0952-7915(01)00275-8","volume":"13","author":"B. Ludewig","year":"2001","unstructured":"Ludewig, B. et al. \"Dendritic cells in autoimmune diseases.\" Curr. Opin. Immunol. 13 (2001) 657\u201362.","journal-title":"Curr. Opin. Immunol"},{"key":"12_CR95","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/35025203","volume":"407","author":"A.J. Lusis","year":"2000","unstructured":"Lusis, A.J. \"Atherosclerosis.\" Nature 407 (2000) 233\u201341.","journal-title":"Nature"},{"key":"12_CR96","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.atherosclerosis.2005.07.028","volume":"186","author":"B. Mackness","year":"2006a","unstructured":"Mackness, B. et al. \"High C-reactive protein and low paraoxonase1 in diabetes as risk factors for coronary heart disease.\" Atherosclerosis 186 (2006a) 396\u2013401.","journal-title":"Atherosclerosis"},{"key":"12_CR97","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0021-9150(98)00095-1","volume":"139","author":"B. Mackness","year":"1998a","unstructured":"Mackness, B. et al. \"Serum paraoxonase (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus.\" Atherosclerosis 139 (1998a) 341\u20139.","journal-title":"Atherosclerosis"},{"key":"12_CR98","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-2796.2005.01554.x","volume":"258","author":"B. Mackness","year":"2005","unstructured":"Mackness, B., P. McElduff, and M.I. Mackness \"The paraoxonase-2-310 polymorphism is associated with the presence of microvascular complications in diabetes mellitus.\" J. Intern. Med. 258 (2005) 363\u20138.","journal-title":"J. Intern. Med"},{"key":"12_CR99","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1161\/01.ATV.0000222924.62641.aa","volume":"26","author":"B. Mackness","year":"2006b","unstructured":"Mackness, B. et al. \"Human paraoxonase-1 overexpression inhibits atherosclerosis in a mouse model of metabolic syndrome.\" Arterioscler. Thromb. Vasc. Biol. 26 (2006b) 1545\u201350.","journal-title":"Arterioscler. Thromb. Vasc. Biol"},{"key":"12_CR100","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0021-9150(94)05524-M","volume":"115","author":"M.I. Mackness","year":"1995b","unstructured":"Mackness, M.I. and P.N. Durrington \"HDL, its enzymes and its potential to influence lipid peroxidation.\" Atherosclerosis 115 (1995b) 243\u201353.","journal-title":"Atherosclerosis"},{"key":"12_CR101","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/S0140-6736(95)92702-6","volume":"346","author":"M.I. Mackness","year":"1995a","unstructured":"Mackness, M.I. and P.N. Durrington \"Paraoxonase: another factor in NIDDM cardiovascular disease.\" Lancet 346 (1995a) 856.","journal-title":"Lancet"},{"key":"12_CR102","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00041433-199808000-00006","volume":"9","author":"M.I. Mackness","year":"1998b","unstructured":"Mackness, M.I. et al. \"Paraoxonase and coronary heart disease.\" Curr. Opin. Lipidol. 9 (1998b) 319\u201324.","journal-title":"Curr. Opin. Lipidol"},{"key":"12_CR103","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1182\/blood-2006-09-046953","volume":"109","author":"J.M. Malleier","year":"2007","unstructured":"Malleier, J.M. et al. \"Regulation of protein C inhibitor (PCI) activity by specific oxidized and negatively charged phospholipids.\" Blood 109 (2007) 4769\u201376.","journal-title":"Blood"},{"key":"12_CR104","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1600-0781.2005.00146.x","volume":"21","author":"R. Mang","year":"2005","unstructured":"Mang, R. and J. Krutmann \"UVA-1 Phototherapy.\" Photodermatol. Photoimmunol. Photomed. 21 (2005) 103\u20138.","journal-title":"Photodermatol. Photoimmunol. Photomed"},{"key":"12_CR105","doi-asserted-by":"crossref","first-page":"28395","DOI":"10.1074\/jbc.274.40.28395","volume":"274","author":"G.K. Marathe","year":"1999","unstructured":"Marathe, G.K. et al. \"Inflammatory platelet-activating factor-like phospholipids in oxidized low density lipoproteins are fragmented alkyl phosphatidylcholines.\" J. Biol. Chem. 274 (1999) 28395\u2013404.","journal-title":"J. Biol. Chem"},{"key":"12_CR106","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1074\/jbc.M211126200","volume":"278","author":"G.K. Marathe","year":"2003","unstructured":"Marathe, G.K., G.A. Zimmerman, and T.M. McIntyre \"Platelet-activating factor acetylhydrolase, and not paraoxonase-1, is the oxidized phospholipid hydrolase of high density lipoprotein particles.\" J. Biol. Chem. 278 (2003) 3937\u201347.","journal-title":"J. Biol. Chem"},{"key":"12_CR107","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S1537-1891(02)00169-6","volume":"38","author":"G.K. Marathe","year":"2002","unstructured":"Marathe, G.K. et al. \"Activation of vascular cells by PAF-like lipids in oxidized LDL.\" Vascular Pharmacol. 38 (2002) 193\u2013200.","journal-title":"Vascular Pharmacol"},{"key":"12_CR108","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.2337\/db06-0723","volume":"55","author":"M. Mastorikou","year":"2006","unstructured":"Mastorikou, M., M. Mackness, and B. Mackness \"Defective metabolism of oxidized phospholipid by HDL from people with type 2 diabetes.\" Diabetes 55 (2006) 3099\u2013103.","journal-title":"Diabetes"},{"key":"12_CR109","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1529\/biophysj.107.103887","volume":"93","author":"J.P. Mattila","year":"2007","unstructured":"Mattila, J.P., K. Sabatini, and P.K. Kinnunen \"Oxidized phospholipids as potential novel drug targets.\" Biophys. J. 93 (2007) 3105\u201312.","journal-title":"Biophys. J"},{"key":"12_CR110","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1177\/1099800404271916","volume":"6","author":"P. Miketova","year":"2005","unstructured":"Miketova, P. et al. \"Oxidative changes in cerebral spinal fluid phosphatidylcholine during treatment for acute lymphoblastic leukemia.\" Biol. Res. Nurs. 6 (2005) 187\u201395.","journal-title":"Biol. Res. Nurs"},{"key":"12_CR111","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/00041433-200310000-00004","volume":"14","author":"Y.I. Miller","year":"2003a","unstructured":"Miller, Y.I. et al. \"Oxidized low density lipoprotein and innate immune receptors.\" Curr. Opin. Lipidol. 14 (2003a) 437\u201345.","journal-title":"Curr. Opin. Lipidol"},{"key":"12_CR112","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1074\/jbc.M209634200","volume":"278","author":"Y.I. Miller","year":"2003b","unstructured":"Miller, Y.I. et al. \"Minimally modified LDL binds to CD14, induces macrophage spreading via TLR4\/MD-2, and inhibits phagocytosis of apoptotic cells.\" J. Biol. Chem. 278 (2003b) 1561\u20138.","journal-title":"J. Biol. Chem"},{"key":"12_CR113","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1291\/hypres.30.85","volume":"30","author":"M. Miyoshi","year":"2007","unstructured":"Miyoshi, M. et al. \"Gene delivery of paraoxonase-1 inhibits neointimal hyperplasia after arterial balloon-injury in rabbits fed a high-fat diet.\" Hypertens. Res. 30 (2007) 85\u201391.","journal-title":"Hypertens. Res"},{"key":"12_CR114","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1172\/JCI25482","volume":"115","author":"A.E. Mullick","year":"2005","unstructured":"Mullick, A.E., P.S. Tobias, and L.K. Curtiss \"Modulation of atherosclerosis in mice by Toll-like receptor 2.\" J. Clin. Invest 115 (2005) 3149\u201356.","journal-title":"J. Clin. Invest"},{"key":"12_CR115","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1096\/fasebj.14.7.835","volume":"14","author":"R.F. Mullins","year":"2000","unstructured":"Mullins, R.F. et al. \"Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease.\" FASEB J. 14 (2000) 835\u201346.","journal-title":"FASEB J"},{"key":"12_CR116","doi-asserted-by":"crossref","first-page":"4356","DOI":"10.1167\/iovs.05-1656","volume":"47","author":"B.R. Mwaikambo","year":"2006","unstructured":"Mwaikambo, B.R. et al. \"Activation of CD36 inhibits and induces regression of inflammatory corneal neovascularization.\" Invest Ophthalmol. Vis. Sci. 47 (2006) 4356\u201364.","journal-title":"Invest Ophthalmol. Vis. Sci"},{"key":"12_CR117","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1006\/abio.1998.2749","volume":"262","author":"T. Nakamura","year":"1998","unstructured":"Nakamura, T., P.M. Henson, and R.C. Murphy \"Occurrence of oxidized metabolites of arachidonic acid esterified to phospholipids in murine lung tissue.\" Anal. Biochem. 262 (1998) 23\u201332.","journal-title":"Anal. Biochem"},{"key":"12_CR118","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.freeradbiomed.2004.09.035","volume":"38","author":"C.J. Ng","year":"2005","unstructured":"Ng, C.J. et al. \"The paraoxonase gene family and atherosclerosis.\" Free Radic. Biol. Med. 38 (2005) 153\u201363.","journal-title":"Free Radic. Biol. Med"},{"key":"12_CR119","doi-asserted-by":"crossref","unstructured":"Nonas, S. et al. \"Oxidized phospholipids reduce ventilator-induced vascular leak and inflammation in vivo.\" Critical Care, 2008.","DOI":"10.1186\/cc6805"},{"key":"12_CR120","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1164\/rccm.200511-1737OC","volume":"173","author":"S. Nonas","year":"2006","unstructured":"Nonas, S. et al. \"Oxidized phospholipids reduce vascular leak and inflammation in rat model of acute lung injury.\" Am. J Respir. Crit Care Med. 173 (2006) 1130\u20138.","journal-title":"Am. J Respir. Crit Care Med"},{"key":"12_CR121","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1172\/JCI118853","volume":"98","author":"W. Palinski","year":"1996","unstructured":"Palinski, W. et al. \"Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma.\" J. Clin. Invest. 98 (1996) 800\u201314.","journal-title":"J. Clin. Invest"},{"key":"12_CR122","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1161\/01.ATV.17.4.680","volume":"17","author":"F. Parhami","year":"1997","unstructured":"Parhami, F. et al. \"Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients.\" Arterioscler. Thromb. Vasc. Biol. 17 (1997) 680\u20137.","journal-title":"Arterioscler. Thromb. Vasc. Biol"},{"key":"12_CR123","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1359\/jbmr.2001.16.1.182","volume":"16","author":"F. Parhami","year":"2001","unstructured":"Parhami, F. et al. \"Atherogenic high-fat diet reduces bone mineralization in mice.\" J. Bone Miner. Res. 16 (2001) 182\u20138.","journal-title":"J. Bone Miner. Res"},{"key":"12_CR124","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1161\/CIRCRESAHA.107.152736","volume":"101","author":"N.A. Pidkovka","year":"2007","unstructured":"Pidkovka, N.A. et al. \"Oxidized phospholipids induce phenotypic switching of vascular smooth muscle cells in vivo and in vitro.\" Circ. Res. 101 (2007) 792\u2013801.","journal-title":"Circ. Res"},{"key":"12_CR125","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/nm1626","volume":"13","author":"E.A. Podrez","year":"2007","unstructured":"Podrez, E.A. et al. \"Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype.\" Nat. Med. 13 (2007) 1086\u201395.","journal-title":"Nat. Med"},{"key":"12_CR126","doi-asserted-by":"crossref","first-page":"38517","DOI":"10.1074\/jbc.M205924200","volume":"277","author":"E.A. Podrez","year":"2002a","unstructured":"Podrez, E.A. et al. \"A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic lesions 1.\" J. Biol. Chem. 277 (2002a) 38517\u201323.","journal-title":"J. Biol. Chem"},{"key":"12_CR127","doi-asserted-by":"crossref","first-page":"38503","DOI":"10.1074\/jbc.M203318200","volume":"277","author":"E.A. Podrez","year":"2002b","unstructured":"Podrez, E.A. et al. \"Identification of a novel family of oxidized phospholipids that serve as ligands for the macrophage scavenger receptor CD36.\" J. Biol. Chem. 277 (2002b) 38503\u201316.","journal-title":"J. Biol. Chem"},{"key":"12_CR128","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/jnr.21206","volume":"85","author":"J. Qin","year":"2007","unstructured":"Qin, J. et al. \"Oxidized phosphatidylcholine is a marker for neuroinflammation in multiple sclerosis brain.\" J. Neurosci. Res. 85 (2007) 977\u201384.","journal-title":"J. Neurosci. Res"},{"key":"12_CR129","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0306-4522(00)00501-7","volume":"102","author":"B.M. Ross","year":"2001","unstructured":"Ross, B.M. et al. \"Elevated activity of phospholipid biosynthetic enzymes in substantia nigra of patients with Parkinson's disease.\" Neuroscience 102 (2001) 899\u2013904.","journal-title":"Neuroscience"},{"key":"12_CR130","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1042\/CS20050089","volume":"109","author":"M.J. Sampson","year":"2005","unstructured":"Sampson, M.J. et al. \"Paraoxonase-1 (PON-1) genotype and activity and in vivo oxidized plasma low-density lipoprotein in Type II diabetes.\" Clin. Sci. (Lond) 109 (2005) 189\u201397.","journal-title":"Clin. Sci. (Lond)"},{"key":"12_CR131","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2337\/diacare.25.3.537","volume":"25","author":"M.J. Sampson","year":"2002","unstructured":"Sampson, M.J. et al. \"Plasma F2 isoprostanes: direct evidence of increased free radical damage during acute hyperglycemia in type 2 diabetes.\" Diabetes Care 25 (2002) 537\u201341.","journal-title":"Diabetes Care"},{"key":"12_CR132","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1084\/jem.20061737","volume":"204","author":"A.T. Shamshiev","year":"2007","unstructured":"Shamshiev, A.T. et al. \"Dyslipidemia inhibits Toll-like receptor-induced activation of CD8alpha-negative dendritic cells and protective Th1 type immunity.\" J. Exp. Med. 204 (2007) 441\u201352.","journal-title":"J. Exp. Med"},{"key":"12_CR133","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1006\/bbrc.1999.0434","volume":"257","author":"H. Shi","year":"1999","unstructured":"Shi, H. et al. \"Formation of phospholipid hydroperoxides and its inhibition by alpha-tocopherol in rat brain synaptosomes induced by peroxynitrite.\" Biochem. Biophys. Res. Commun. 257 (1999) 651\u20136.","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"12_CR134","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/28406","volume":"394","author":"D.M. Shih","year":"1998","unstructured":"Shih, D.M. et al. \"Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis.\" Nature 394 (1998) 284\u20137.","journal-title":"Nature"},{"key":"12_CR135","doi-asserted-by":"crossref","first-page":"17527","DOI":"10.1074\/jbc.M910376199","volume":"275","author":"D.M. Shih","year":"2000","unstructured":"Shih, D.M. et al. \"Combined serum paraoxonase knockout\/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis.\" J. Biol. Chem. 275 (2000) 17527\u201335.","journal-title":"J. Biol. Chem"},{"key":"12_CR136","doi-asserted-by":"crossref","first-page":"11104","DOI":"10.1016\/S0021-9258(18)99133-7","volume":"266","author":"P.L. Smiley","year":"1991","unstructured":"Smiley, P.L. et al. \"Oxidatively fragmented phosphatidylcholines activate human neutrophils through the receptor for platelet-activating factor.\" J. Biol. Chem. 266 (1991) 11104\u201310.","journal-title":"J. Biol. Chem"},{"key":"12_CR137","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1161\/01.ATV.20.10.2248","volume":"20","author":"G. Subbanagounder","year":"2000","unstructured":"Subbanagounder, G. et al. \"Determinants of bioactivity of oxidized phospholipids. Specific oxidized fatty acyl groups at the sn-2 position.\" Arterioscler. Thromb. Vasc. Biol. 20 (2000) 2248\u201354.","journal-title":"Arterioscler. Thromb. Vasc. Biol"},{"key":"12_CR138","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1161\/01.RES.85.4.311","volume":"85","author":"G. Subbanagounder","year":"1999","unstructured":"Subbanagounder, G. et al. \"Evidence that phospholipid oxidation products and\/or platelet-activating factor play an important role in early atherogenesis : in vitro and In vivo inhibition by WEB 2086.\" Circ. Res. 85 (1999) 311\u20138.","journal-title":"Circ. Res"},{"key":"12_CR139","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/S0891-5849(00)00233-1","volume":"28","author":"G. Subbanagounder","year":"2000","unstructured":"Subbanagounder, G., A.D. Watson, and J.A. Berliner \"Bioactive products of phospholipid oxidation: isolation, identification, measurement and activities.\" Free Radic. Biol. Med. 28 (2000) 1751\u201361.","journal-title":"Free Radic. Biol. Med"},{"key":"12_CR140","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1074\/jbc.M509769200","volume":"281","author":"M. Sun","year":"2006","unstructured":"Sun, M. et al. \"Light-induced oxidation of photoreceptor outer segment phospholipids generates ligands for CD36-mediated phagocytosis by retinal pigment epithelium: a potential mechanism for modulating outer segment phagocytosis under oxidant stress conditions.\" J. Biol. Chem. 281 (2006) 4222\u201330.","journal-title":"J. Biol. Chem"},{"key":"12_CR141","first-page":"772","volume":"13","author":"M. Suzuki","year":"2007","unstructured":"Suzuki, M. et al. \"Oxidized phospholipids in the macula increase with age and in eyes with age-related macular degeneration.\" Mol. Vis. 13(2007): 772\u20138.","journal-title":"Mol. Vis"},{"key":"12_CR142","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1161\/hc4101.097518","volume":"104","author":"E. Svenungsson","year":"2001","unstructured":"Svenungsson, E. et al. \"Risk factors for cardiovascular disease in systemic lupus erythematosus.\" Circulation 104 (2001) 1887\u201393.","journal-title":"Circulation"},{"key":"12_CR143","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1194\/jlr.R400015-JLR200","volume":"46","author":"P. Tobias","year":"2005","unstructured":"Tobias, P. and L.K. Curtiss \"Thematic review series: The immune system and atherogenesis. Paying the price for pathogen protection: toll receptors in atherogenesis.\" J. Lipid Res. 46 (2005) 404\u201311.","journal-title":"J. Lipid Res"},{"key":"12_CR144","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11883-006-0065-1","volume":"8","author":"S. Tsimikas","year":"2006b","unstructured":"Tsimikas, S. \"Oxidized low-density lipoprotein biomarkers in atherosclerosis.\" Curr. Atheroscler. Rep. 8 (2006b) 55\u201361.","journal-title":"Curr. Atheroscler. Rep"},{"key":"12_CR145","doi-asserted-by":"crossref","first-page":"9P","DOI":"10.1016\/j.amjcard.2006.09.015","volume":"98","author":"S. Tsimikas","year":"2006a","unstructured":"Tsimikas, S. \"Oxidative biomarkers in the diagnosis and prognosis of cardiovascular disease.\" Am. J. Cardiol. 98 (2006a) 9P\u201317P.","journal-title":"Am. J. Cardiol"},{"key":"12_CR146","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1161\/01.ATV.0000251501.86410.03","volume":"27","author":"S. Tsimikas","year":"2007","unstructured":"Tsimikas, S. et al. \"Increased plasma oxidized phospholipid:apolipoprotein B-100 ratio with concomitant depletion of oxidized phospholipids from atherosclerotic lesions after dietary lipid-lowering: a potential biomarker of early atherosclerosis regression.\" Arterioscler. Thromb. Vasc. Biol. 27 (2007) 175\u201381.","journal-title":"Arterioscler. Thromb. Vasc. Biol"},{"key":"12_CR147","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1056\/NEJMoa043175","volume":"353","author":"S. Tsimikas","year":"2005","unstructured":"Tsimikas, S. et al. \"Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease.\" N. Engl. J Med. 353 (2005) 46\u201357.","journal-title":"N. Engl. J Med"},{"key":"12_CR148","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1016\/j.jacc.2006.03.001","volume":"47","author":"S. Tsimikas","year":"2006","unstructured":"Tsimikas, S. et al. \"Oxidized phospholipids predict the presence and progression of carotid and femoral atherosclerosis and symptomatic cardiovascular disease: five-year prospective results from the Bruneck study.\" J. Am. Coll. Cardiol. 47 (2006) 2219\u201328.","journal-title":"J. Am. Coll. Cardiol"},{"key":"12_CR149","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1161\/01.ATV.21.1.95","volume":"21","author":"S. Tsimikas","year":"2001","unstructured":"Tsimikas, S., W. Palinski, and J.L. Witztum \"Circulating autoantibodies to oxidized LDL correlate with arterial accumulation and depletion of oxidized LDL in LDL receptor-deficient mice.\" Arterioscler. Thromb. Vasc. Biol. 21 (2001) 95\u2013100.","journal-title":"Arterioscler. Thromb. Vasc. Biol"},{"key":"12_CR150","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1161\/01.ATV.0000280571.28102.d4","volume":"27","author":"S. Tsimikas","year":"2007","unstructured":"Tsimikas, S., L.D. Tsironis, and A.D. Tselepis \"New insights into the role of lipoprotein(a)-associated lipoprotein-associated phospholipase A2 in atherosclerosis and cardiovascular disease.\" Arterioscler. Thromb. Vasc. Biol. 27 (2007) 2094\u20139.","journal-title":"Arterioscler. Thromb. Vasc. Biol"},{"key":"12_CR151","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1161\/01.CIR.103.15.1930","volume":"103","author":"S. Tsimikas","year":"2001","unstructured":"Tsimikas, S. and J.L. Witztum \"Measuring circulating oxidized low-density lipoprotein to evaluate coronary risk.\" Circulation 103 (2001) 1930\u20132.","journal-title":"Circulation"},{"key":"12_CR152","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1194\/jlr.M400176-JLR200","volume":"45","author":"P. Turunen","year":"2004","unstructured":"Turunen, P. et al. \"Adenovirus-mediated gene transfer of Lp-PLA2 reduces LDL degradation and foam cell formation in vitro.\" J. Lipid Res. 45 (2004) 1633\u20139.","journal-title":"J. Lipid Res"},{"key":"12_CR153","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/01.CIR.0000023623.87083.4F","volume":"106","author":"A. Tward","year":"2002","unstructured":"Tward, A. et al. \"Decreased atherosclerotic lesion formation in human serum paraoxonase transgenic mice.\" Circulation 106 (2002) 484\u201390.","journal-title":"Circulation"},{"key":"12_CR154","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1021\/tx010183i","volume":"15","author":"C. Uhlson","year":"2002","unstructured":"Uhlson, C. et al. \"Oxidized phospholipids derived from ozone-treated lung surfactant extract reduce macrophage and epithelial cell viability.\" Chem. Res. Toxicol. 15 (2002) 896\u2013906.","journal-title":"Chem. Res. Toxicol"},{"key":"12_CR155","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1084\/jem.20011450","volume":"195","author":"J.P. Walterscheid","year":"2002","unstructured":"Walterscheid, J.P., S.E. Ullrich, and D.X. Nghiem \"Platelet-activating factor, a molecular sensor for cellular damage, activates systemic immune suppression.\" J. Exp. Med. 195 (2002) 171\u20139.","journal-title":"J. Exp. Med"},{"key":"12_CR156","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1161\/01.ATV.0000079340.80744.B8","volume":"23","author":"K.A. Walton","year":"2003a","unstructured":"Walton, K.A. et al. \"Specific phospholipid oxidation products inhibit ligand activation of toll-like receptors 4 and 2.\" Arterioscler. Thromb. Vasc. Biol. 23 (2003a) 1197\u2013203.","journal-title":"Arterioscler. Thromb. Vasc. Biol"},{"key":"12_CR157","doi-asserted-by":"crossref","first-page":"29661","DOI":"10.1074\/jbc.M300738200","volume":"278","author":"K.A. Walton","year":"2003b","unstructured":"Walton, K.A. et al. \"Receptors involved in the oxidized 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine-mediated synthesis of interleukin-8. A role for Toll-like receptor 4 and a glycosylphosphatidylinositol-anchored protein.\" J. Biol. Chem. 278 (2003b) 29661\u20136.","journal-title":"J. Biol. Chem"},{"key":"12_CR158","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1172\/JCI118359","volume":"96","author":"A.D. Watson","year":"1995","unstructured":"Watson, A.D. et al. \"Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein.\" J. Clin. Invest. 96 (1995) 2882\u201391.","journal-title":"J. Clin. Invest"},{"key":"12_CR159","doi-asserted-by":"crossref","first-page":"13597","DOI":"10.1074\/jbc.272.21.13597","volume":"272","author":"A.D. Watson","year":"1997","unstructured":"Watson, A.D. et al. \"Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte\/endothelial interactions and evidence for their presence in vivo.\" J. Biol. Chem. 272 (1997) 13597\u2013607.","journal-title":"J. Biol. Chem"},{"key":"12_CR160","first-page":"831","volume":"40","author":"G.S. Wu","year":"1999","unstructured":"Wu, G.S. and N.A. Rao \"Activation of NADPH oxidase by docosahexaenoic acid hydroperoxide and its inhibition by a novel retinal pigment epithelial protein.\" Invest Ophthalmol. Vis. Sci. 40 (1999) 831\u20139.","journal-title":"Invest Ophthalmol. Vis. Sci"},{"key":"12_CR161","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0021-9150(99)00385-8","volume":"150","author":"Y. Yamada","year":"2000","unstructured":"Yamada, Y. et al. \"Correlations between plasma platelet-activating factor acetylhydrolase (PAF-AH) activity and PAF-AH genotype, age, and atherosclerosis in a Japanese population.\" Atherosclerosis 150 (2000) 209\u201316.","journal-title":"Atherosclerosis"},{"key":"12_CR162","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1373\/clinchem.2006.070672","volume":"52","author":"A. Zalewski","year":"2006","unstructured":"Zalewski, A. et al. \"Lp-PLA2: a new kid on the block.\" Clin. Chem. 52 (2006) 1645\u201350.","journal-title":"Clin. Chem"},{"key":"12_CR163","doi-asserted-by":"crossref","first-page":"46116","DOI":"10.1074\/jbc.M209124200","volume":"277","author":"R. Zhang","year":"2002","unstructured":"Zhang, R. et al. \"Myeloperoxidase functions as a major enzymatic catalyst for initiation of lipid peroxidation at sites of inflammation.\" J Biol Chem. 277 (2002) 46116\u201322.","journal-title":"J Biol Chem"},{"key":"12_CR164","doi-asserted-by":"crossref","first-page":"19828","DOI":"10.1074\/jbc.M007506200","volume":"276","author":"S. Zieseniss","year":"2001","unstructured":"Zieseniss, S. et al. \"Modified phosphatidylethanolamine as the active component of oxidized low density lipoprotein promoting platelet prothrombinase activity.\" J. Biol. Chem. 276 (2001) 19828\u201335.","journal-title":"J. Biol. Chem"},{"key":"12_CR165","doi-asserted-by":"crossref","first-page":"S294","DOI":"10.1097\/00003246-200205001-00020","volume":"30","author":"G.A. Zimmerman","year":"2002","unstructured":"Zimmerman, G.A. et al. \"The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis.\" Crit Care Med. 30 (2002) S294\u2013S301.","journal-title":"Crit Care Med"}],"container-title":["Subcellular Biochemistry","Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4020-8830-8_12.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T09:04:31Z","timestamp":1631696671000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4020-8830-8_12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[null]]},"ISBN":["9781402088308","9781402088315"],"references-count":165,"URL":"https:\/\/doi.org\/10.1007\/978-1-4020-8830-8_12","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-1-4020-8831-5","asserted-by":"object"}]},"ISSN":["0306-0225"],"issn-type":[{"value":"0306-0225","type":"print"}],"subject":[]}}